Viewing Study NCT02273050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-04 @ 1:47 PM
Study NCT ID: NCT02273050
Status: COMPLETED
Last Update Posted: 2018-02-05
First Post: 2014-10-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-12
Start Date Type: None
Primary Completion Date: 2016-08
Primary Completion Date Type: ACTUAL
Completion Date: 2016-08
Completion Date Type: ACTUAL
First Submit Date: 2014-10-22
First Submit QC Date: None
Study First Post Date: 2014-10-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-08-01
Results First Submit QC Date: None
Results First Post Date: 2018-02-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-08-01
Last Update Post Date: 2018-02-05
Last Update Post Date Type: ACTUAL